Clinical features and prognostic analysis of the blastoid variant of mantle cell lymphoma: An analysis of 20 patients from two centers
Sai Huang,
Shaomei Liu,
Hongmei Jing,
Ping Chen,
Lili Dong,
Xiaoyu Hao,
Jian Bo,
Lu Sun,
Yu Zhao
Affiliations
Sai Huang
Department of Hematology, Senior Department of Hematology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China; Department of Hematology, The First Medical Center of PLA General Hospital, Beijing 100853, China
Shaomei Liu
Medical School of Chinese PLA General Hospital, Beijing 100853, China; Department of Clinical Laboratory, The First Medical Center of PLA General Hospital, Beijing 100853, China
Hongmei Jing
Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, China
Ping Chen
Medical School of Chinese PLA General Hospital, Beijing 100853, China
Lili Dong
Medical School of Chinese PLA General Hospital, Beijing 100853, China
Xiaoyu Hao
Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, China
Jian Bo
Department of Hematology, Senior Department of Hematology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China; Department of Hematology, The First Medical Center of PLA General Hospital, Beijing 100853, China
Lu Sun
Department of Pathology, The First Medical Center of PLA General Hospital, Beijing 100853, China
Yu Zhao
Department of Hematology, Senior Department of Hematology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China; Department of Hematology, The First Medical Center of PLA General Hospital, Beijing 100853, China; Corresponding author: Department of Hematology, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.